Publisher Full Text
Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement.Ann Intern Med. 2012 Jul 17; 157(2):120-34.AIM
Abstract
DESCRIPTION
Update of the 2008 U.S. Preventive Services Task Force (USPSTF) recommendation statement on screening for prostate cancer.
METHODS
The USPSTF reviewed new evidence on the benefits and harms of prostate-specific antigen (PSA)-based screening for prostate cancer, as well as the benefits and harms of treatment of localized prostate cancer.
RECOMMENDATION
The USPSTF recommends against PSA-based screening for prostate cancer (grade D recommendation).This recommendation applies to men in the general U.S. population, regardless of age. This recommendation does not include the use of the PSA test for surveillance after diagnosis or treatment of prostate cancer; the use of the PSA test for this indication is outside the scope of the USPSTF.
Links
MeSH
Pub Type(s)
Journal Article
Practice Guideline
Research Support, U.S. Gov't, P.H.S.
Language
eng
PubMed ID
22801674
Citation
Moyer, Virginia A., and U.S. Preventive Services Task Force. "Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement." Annals of Internal Medicine, vol. 157, no. 2, 2012, pp. 120-34.
Moyer VA, U.S. Preventive Services Task Force. Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2012;157(2):120-34.
Moyer, V. A. (2012). Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement. Annals of Internal Medicine, 157(2), 120-34. https://doi.org/10.7326/0003-4819-157-2-201207170-00459
Moyer VA, U.S. Preventive Services Task Force. Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med. 2012 Jul 17;157(2):120-34. PubMed PMID: 22801674.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement.
AU - Moyer,Virginia A,
AU - ,,
PY - 2012/7/18/entrez
PY - 2012/7/18/pubmed
PY - 2012/9/25/medline
SP - 120
EP - 34
JF - Annals of internal medicine
JO - Ann Intern Med
VL - 157
IS - 2
N2 - DESCRIPTION: Update of the 2008 U.S. Preventive Services Task Force (USPSTF) recommendation statement on screening for prostate cancer. METHODS: The USPSTF reviewed new evidence on the benefits and harms of prostate-specific antigen (PSA)-based screening for prostate cancer, as well as the benefits and harms of treatment of localized prostate cancer. RECOMMENDATION: The USPSTF recommends against PSA-based screening for prostate cancer (grade D recommendation).This recommendation applies to men in the general U.S. population, regardless of age. This recommendation does not include the use of the PSA test for surveillance after diagnosis or treatment of prostate cancer; the use of the PSA test for this indication is outside the scope of the USPSTF.
SN - 1539-3704
UR - https://www.unboundmedicine.com/medline/citation/22801674/full_citation
L2 - https://www.acpjournals.org/doi/10.7326/0003-4819-157-2-201207170-00459?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub=pubmed
DB - PRIME
DP - Unbound Medicine
ER -
